1. 120 RESULTS OF THE MULTICENTER, PHASE II STUDY OF THE SAFETY OF LENALIDOMIDE MONOTHERAPY IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS) ASSOCIATED WITH AN ISOLATED DEL(5Q). Issue 1 (April 2015) Authors: Schuler, E.; Schemenau, J.; Giagounidis, A.; Haase, D.; Büsche, G.; Platzbecker, U.; Nolte, F.; Götze, K.; Schlenk, R.F.; Ganser, A.; Letsch, A.; Lübbert, M.; Schafhausen, P.; Bug, G.; Germing, U. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S62 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 245 CHOICE OF THERAPY HAS THE STRONGEST IMPACT ON SURVIVAL IN OLDER ADULTS WITH ACUTE MYELOID LEUKEMIA OR AML AFTER MYELODYSPLASTIC SYNDROME. Issue 1 (April 2015) Authors: Rumcheva, I.; Schemenau, J.; Hildebrandt, B.; Kündgen, A.; Schroeder, T.; Kondakci, M.; Kobbe, G.; Haas, R.; Germing, U. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S122 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 317 ASXL1 MUTATION IS ASSOCIATED TO LOWER PLATELET COUNTS AND DECREASED BONE MARROW CELLULARITY IN MDS. Issue 1 (April 2015) Authors: Schemenau, J.; Betz, B.; Hildebrandt, B.; Baldus, S.; Kündgen, A.; Neukirchen, J.; Strupp, C.; Haas, R.; Germing, U. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S157 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 318 THE IPSS-R HAS PROGNOSTIC IMPACT IN UNTREATED PATIENTS WITH MDS DEL(5Q). Issue 1 (April 2015) Authors: Schemenau, J.; Lauseker, M.; Hildebrandt, B.; Fenaux, P.; Pfeilstöcker, M.; Valent, P.; Platzbecker, U.; Kündgen, A.; Bug, G.; Haas, R.; Germing, U. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S157 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 81 LONG-TERM OUTCOME OF LOWER RISK MDS PATIENTS RECEIVING ESA, AND IMPACT OF POST-ESA TREATMENTS ON SURVIVAL: A RETROSPECTIVE STUDY FROM THE GFM, DÜSSELDORF, AND GESMD REGISTRIES. (April 2015) Authors: Park, S.; Hamel, J.F.; Kelaidi, C.; Campelo, M. Diez; Schemenau, J.; Sapena, R.; Goetze, K.; Mueller-Thomas, K.; Beyne-Rauzy, O.; Stamatoullas, A.; Guerci-Bresler, A.; Cony-Makhoul, P.; Courby, S.; Cheze, S.; Rose, C.; Vey, N.; Germing, U.; Sanz, G.; Fenaux, P.; Dreyfus, F. Journal: Leukemia research Issue: Volume 39(2015:Apr.) Supplement 1 Page Start: S39 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗